Literature DB >> 23852690

Validation of OMERACT preliminary rheumatoid arthritis flare domains in the NOR-DMARD study.

Elisabeth Lie1, Thasia G Woodworth2, Robin Christensen3, Tore K Kvien1, Vivien Bykerk4, Daniel E Furst2, Clifton O Bingham5, Ernest H Choy6.   

Abstract

OBJECTIVE: Domains identified as a result of qualitative research and Delphi exercises to assess rheumatoid arthritis (RA) flare include pain, function, swollen and tender joints, patient and physician global, laboratory measures, participation, stiffness, self-management and fatigue. Here we examine aspects of construct and content validity of these domains in a longitudinal observational study.
METHODS: A total of 1195 patients with RA treated with non-biological disease-modifying antirheumatic drugs (DMARDs) or biologics were eligible for the analyses. Working definitions of 'flare' included patient-reported worsening between 3 and 6 months (primary) and treatment change at 6 months (DMARDs and/or systemic corticosteroids) (secondary). Available outcome measures were mapped to the flare domains. Changes between 3 and 6 months were compared between patients with and without 'flare'. Convergent and divergent construct validity and content validity were assessed by correlation analyses and logistic regression analysis, respectively.
RESULTS: Applying the flare working definition based on patient-reported worsening, standardised mean differences (SMDs) were >0.5 for the majority of outcomes. The largest SMDs were observed for Pain visual analogue scale (1.30), SF-36 Bodily pain (1.24), Patient global (1.20) and morning stiffness intensity (1.17). The flare working definition based on treatment change yielded lower SMDs (<0.5 for most variables). Consistently stronger intradomain than corresponding interdomain correlations supported convergent and divergent validity of the domains.
CONCLUSIONS: Probing a flare definition via outcome measures, the identified flare domains discriminated well between patients with and without worsening. Interdomain and intradomain correlation and logistic regression analyses provide further support for construct and content validity of the identified flare domains. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Outcomes research; Patient perspective; Rheumatoid Arthritis

Mesh:

Substances:

Year:  2013        PMID: 23852690     DOI: 10.1136/annrheumdis-2013-203496

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  7 in total

1.  Content and Construct Validity, Reliability, and Responsiveness of the Rheumatoid Arthritis Flare Questionnaire: OMERACT 2016 Workshop Report.

Authors:  Susan J Bartlett; Skye P Barbic; Vivian P Bykerk; Ernest H Choy; Rieke Alten; Robin Christensen; Alfons den Broeder; Bruno Fautrel; Daniel E Furst; Francis Guillemin; Sarah Hewlett; Amye L Leong; Anne Lyddiatt; Lyn March; Pamela Montie; Christoph Pohl; Marieke Scholte Voshaar; Thasia G Woodworth; Clifton O Bingham
Journal:  J Rheumatol       Date:  2017-08-15       Impact factor: 4.666

2.  Patient self-assessment of flare in rheumatoid arthritis: criterion and concurrent validity of the Flare instrument.

Authors:  Annette de Thurah; Thomas Maribo; Kristian Stengaard-Pedersen
Journal:  Clin Rheumatol       Date:  2014-12-18       Impact factor: 2.980

Review 3.  Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop.

Authors:  Vivian P Bykerk; Elisabeth Lie; Susan J Bartlett; Rieke Alten; Annelies Boonen; Robin Christensen; Daniel E Furst; Sarah Hewlett; Amye L Leong; Anne Lyddiatt; Lyn March; James E May; Pam Montie; Ana-Maria Orbai; Christoph Pohl; Marieke Scholte Voshaar; Thasia Woodworth; Clifton O Bingham; Ernest H Choy
Journal:  J Rheumatol       Date:  2014-03-01       Impact factor: 4.666

Review 4.  Patient-reported outcomes in core domain sets for rheumatic diseases.

Authors:  Lilian H D van Tuyl; Maarten Boers
Journal:  Nat Rev Rheumatol       Date:  2015-09-01       Impact factor: 20.543

5.  Evaluation of the Disease Activity Score in Twenty-Eight Joints-Based Flare Definitions in Rheumatoid Arthritis: Data From a Three-Year Clinical Trial.

Authors:  Maxime Dougados; Tom W J Huizinga; Ernest H Choy; Clifton O Bingham; Maher Aassi; Corrado Bernasconi
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-12       Impact factor: 4.794

6.  Disease flares in rheumatoid arthritis are associated with joint damage progression and disability: 10-year results from the BeSt study.

Authors:  Iris M Markusse; Linda Dirven; Andreas H Gerards; Johannes H L M van Groenendael; H Karel Ronday; Pit J S M Kerstens; Willem F Lems; Tom W J Huizinga; Cornelia F Allaart
Journal:  Arthritis Res Ther       Date:  2015-08-31       Impact factor: 5.156

7.  Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain Set.

Authors:  Vivian P Bykerk; Clifton O Bingham; Ernest H Choy; Daming Lin; Rieke Alten; Robin Christensen; Daniel E Furst; Sarah Hewlett; Amye Leong; Lyn March; Thasia Woodworth; Gilles Boire; Boulos Haraoui; Carol Hitchon; Shahin Jamal; Edward C Keystone; Janet Pope; Diane Tin; J Carter Thorne; Susan J Bartlett
Journal:  RMD Open       Date:  2016-05-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.